| Segment Reporting, Reconciliation of Profit (Loss) by Segment to Consolidated |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Third Quarter 2026 | | (Dollars in millions) | Advanced Materials | | Additives & Functional Products | | Chemical Intermediates | | Fibers | | Total Operating Segments | | Sales | $ | 762 | | | $ | 784 | | | $ | 580 | | | $ | 255 | | | $ | 2,381 | | | | | | | | | | | | | Cost of sales | 574 | | | 572 | | | 514 | | | 183 | | | 1,843 | | | Selling, general, and administrative expenses | 70 | | | 47 | | | 25 | | | 17 | | | 159 | | Other segment items (1) | 15 | | | 11 | | | 6 | | | 3 | | | 35 | | | Adjusted EBIT | 103 | | | 154 | | | 35 | | | 52 | | | 344 | | | | | | | | | | | | | Reconciliation of segment Adjusted EBIT to consolidated earnings before income taxes ("EBT"): | | "Other" Adjusted EBIT (2) | | | | | | | | | (39) | | | | | | | | | | | | | | | | | | | | | | | | | | | | Net interest expense | | | | (56) | | | Consolidated EBT | | | | | | | | | $ | 249 | | | | | | | | | | | | | Third Quarter 2025 | | (Dollars in millions) | Advanced Materials | | Additives & Functional Products | | Chemical Intermediates | | Fibers | | Total Operating Segments | | Sales | $ | 728 | | | $ | 716 | | | $ | 499 | | | $ | 254 | | | $ | 2,197 | | | | | | | | | | | | | Cost of sales | 587 | | | 530 | | | 469 | | | 167 | | | 1,753 | | | Selling, general, and administrative expenses | 65 | | | 43 | | | 22 | | | 15 | | | 145 | | Other segment items (1) | 23 | | | 15 | | | 7 | | | 5 | | | 50 | | | Adjusted EBIT | 53 | | | 128 | | | 1 | | | 67 | | | 249 | | | | | | | | | | | | | Reconciliation of segment Adjusted EBIT to consolidated EBT: | | "Other" Adjusted EBIT (2) | | | | | | | | | (39) | | | Non-core items impacting EBIT | | | | | Cost of sales impact from restructuring activities (3) | | | | (2) | | Asset impairments, restructuring, and other charges, net (3) | | | | (20) | | | | | | | | | | | | | | | | | | | | | | | Net interest expense | | | | | | | | | (54) | | | Consolidated EBT | | | | | | | | | $ | 134 | | | | | | | | | | | | | First Nine Months 2026 | | (Dollars in millions) | Advanced Materials | | Additives & Functional Products | | Chemical Intermediates | | Fibers | | Total Operating Segments | | Sales | $ | 2,294 | | | $ | 2,330 | | | $ | 1,718 | | | $ | 723 | | | $ | 7,065 | | | | | | | | | | | | | Cost of sales | 1,747 | | | 1,702 | | | 1,543 | | | 529 | | | 5,521 | | | | | | | | | | | | | Selling, general, and administrative expenses | 215 | | | 147 | | | 83 | | | 51 | | | 496 | | Other segment items (1) | 51 | | | 34 | | | 17 | | | 10 | | | 112 | | | Adjusted EBIT | 281 | | | 447 | | | 75 | | | 133 | | | 936 | | | | | | | | | | | | | Reconciliation of segment Adjusted EBIT to consolidated EBT: | | "Other" Adjusted EBIT (2) | | | | | | | | | (111) | | | Non-core items impacting EBIT | | | | | Cost of sales impact from restructuring activities (3) | | | | (3) | | Asset impairments, restructuring, and other charges, net (3) | | | | (10) | | | | | | | Environmental and other costs (4) | | | | (8) | | | Net interest expense | | | | (163) | | | Consolidated EBT | | | | | | | | | $ | 641 | | | | | | | | | | | | | First Nine Months 2025 | | (Dollars in millions) | Advanced Materials | | Additives & Functional Products | | Chemical Intermediates | | Fibers | | Total Operating Segments | | Sales | $ | 2,224 | | | $ | 2,218 | | | $ | 1,507 | | | $ | 816 | | | $ | 6,765 | | | | | | | | | | | | | Cost of sales | 1,666 | | | 1,614 | | | 1,426 | | | 517 | | | 5,223 | | | Gross profit | 558 | | | 604 | | | 81 | | | 299 | | | | | Selling, general, and administrative expenses | 198 | | | 137 | | | 71 | | | 50 | | | 456 | | Other segment items (1) | 70 | | | 45 | | | 20 | | | 13 | | | 148 | | | Adjusted EBIT | 290 | | | 422 | | | (10) | | | 236 | | | 938 | | | | | | | | | | | | | Reconciliation of segment Adjusted EBIT to consolidated EBT: | | "Other" Adjusted EBIT (2) | | | | | | | | | (142) | | | Non-core items impacting EBIT | | | | | Cost of sales impact from restructuring activities (3) | | | | (2) | | Asset impairments, restructuring, and other charges, net (3) | | | | (42) | | | | | | | Environmental and other costs (4) | | | | (40) | | | Net interest expense | | | | (156) | | | Consolidated EBT | | | | | | | | | $ | 556 | | (1)Other segment items for each reportable segment included R&D expenses, other components of post-employment (benefit) cost, net, and other (income) charges, net. (2)"Other" is not considered an operating segment. "Other" included sales and costs from growth initiatives and businesses, R&D costs, pension and other postretirement benefit plans income (expense), net, and other income (charges), net that are not identifiable to an operating segment. (3)See Note 11, "Asset Impairments, Restructuring, and Other Charges, Net", for a description of included items. (4)Environmental and other costs from previously divested or non-operational sites and product lines primarily related to increased chemical costs for groundwater treatment and new and extended remediation costs reported in "Other" to be paid out over 30 years. |
|
| Segment Reporting, Reconciliation of Asset by Segment to Consolidated |
| | | | | | | | | | | | | | | | | | | | | | | | | (Dollars in millions) | Third Quarter | | First Nine Months | | Sales by Segment | 2026 | | 2025 | | 2026 | | 2025 | | Advanced Materials | $ | 762 | | | $ | 728 | | | $ | 2,294 | | | $ | 2,224 | | | Additives & Functional Products | 784 | | | 716 | | | 2,330 | | | 2,218 | | | Chemical Intermediates | 580 | | | 499 | | | 1,718 | | | 1,507 | | | Fibers | 255 | | | 254 | | | 723 | | | 816 | | | Total Sales by Operating Segment | 2,381 | | | 2,197 | | | 7,065 | | | 6,765 | | | Other | 4 | | | 5 | | | 10 | | | 14 | | | Total Sales | $ | 2,385 | | | $ | 2,202 | | | $ | 7,075 | | | $ | 6,779 | |
|